Global
Factbook
Other
Activities that are not allocated to any of the divisions are recorded under Other. These include commodity trading, engineering and other services, as well as rental income and leases. Discontinued operations and certain activities remaining after divestitures are also reported here.
The following activities are also presented under Other:
- The steering of the BASF Group by corporate headquarters.
- Cross-divisional corporate research, which includes plant biotechnology research, works on long-term topics of strategic importance to the BASF Group. Furthermore, it focuses on the development of specific key technologies, which are of overriding importance for the divisions.
- Trade with renewable energies as well as the activities of the Net Zero Accelerator unit, which bundles cross-company projects to achieve climate protection targets.
- Foreign currency results not allocated to the segments and measurement effects from the hedging of raw materials price and foreign currency exchange risks; as well as gains and losses from the long-term incentive programs (LTI programs).
- Remanent fixed costs resulting from organizational changes or restructuring that are not allocated to a division; idle capacity costs from internal human resource platforms; and consolidation effects that cannot be allocated to a division.
In 2023, sales in Other amounted to €3,220 million, €1,148 million below the prior-year figure. The decline in sales was mainly due to lower sales in both commodity and energy trading.
EBIT before special items improved by €135 million year on year to –€614 million. This was mainly driven by higher contributions from other businesses compared with the previous year as well as lower expenses in connection with corporate research and the corporate headquarters.
EBIT decreased by €256 million compared with 2022 to –€778 million. This was primarily due to special income in 2022 attributable to the partial divestiture of the interest in the Hollandse Kust Zuid wind farm.
| Million € | 2023 | 2022 | +/– |
| Sales | 3,220 |
4,368 |
–26.3% |
| Income from operations before depreciation, amortization and special items | –466 |
–594 |
21.5% |
| Income from operations before depreciation and amortization (EBITDA) | –626 |
–368 |
–70.1% |
| Depreciation and amortization2 | 153 |
155 |
–1.4% |
| Income from operations (EBIT) | –778 |
–523 |
–48.9% |
| Special items | –164 |
226 |
. |
| EBIT before special items | –614 |
–749 |
18.0% |
of which costs for cross-divisional corporate research |
–242 |
–325 |
25.5% |
costs of corporate headquarters |
–222 |
–258 |
14.0% |
other businesses |
83 |
–43 |
. |
foreign currency results, hedging and other measurement effects |
–29 |
33 |
. |
miscellaneous income and expenses |
–204 |
–156 |
–30.8% |
| Investments including acquisitions3 | 195 |
268 |
–27.1% |
| Assets4 | 14,393 |
16,803 |
–14.3% |
| Research and development expenses | 356 |
381 |
–6.4% |
1 Information on the composition of Other can be found in the BASF Report 2023.
2 Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
3 Additions to property, plant and equipment and intangible assets
4 Includes assets of businesses recognized under Other and reconciliation to assets of the BASF Group